Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York.


Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
08 2020
Historique:
received: 04 05 2020
accepted: 13 05 2020
pubmed: 23 6 2020
medline: 28 8 2020
entrez: 23 6 2020
Statut: ppublish

Résumé

The COVID-19 virus is a devastating pandemic that has impacted the US healthcare system significantly. More than one study reported a significant decrease in acute coronary syndrome admissions during that pandemic which is still due to unknown reasons. This is a retrospective non-controlled multi-centered study of 180 patients (117 males and 63 females) with acute coronary syndrome (STEMI and NSTEMI) admitted during March/April of 2019 and March/April 2020 in Upstate New York. A total of 113 patients (61.9% males, 38.1% females) with a mean age of 72.3 ± 14.2 presented during March/April 2019 with ACS (STEMI + NSTEMI) while only 67 (70.1% males, 29.9% females) COVID-19 negative patients with a mean age of 65.1 ± 14.5 presented during the same period (March/April) in 2020. This is a drop by 40.7% (P < .05) of total ACS cases during the COVID-19 pandemic. In NSTEMI patients, 36.4% presented late (>24 hours of symptoms) during the COVID-19 pandemic in comparison with 2019 (27.1%, P = .033). The COVID-19 pandemic led to a substantial drop by 40.7% (P < .05) of total ACS admissions in our area. This decrease in hospital admissions and late presentations can be a worrisome sign for an increase in future complications of myocardial infarctions.

Identifiants

pubmed: 32569892
pii: S0002-8703(20)30146-0
doi: 10.1016/j.ahj.2020.05.009
pmc: PMC7244433
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-151

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Eur Heart J. 2020 May 14;41(19):1852-1853
pubmed: 32297932
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497

Auteurs

Nabil Braiteh (N)

United Health Services Hospitals, Heart and Vascular Institute, Wilson Regional Medical Center, Department of Cardiology, NY, USA. Electronic address: nab.braiteh@gmail.com.

Wajeeh Ur Rehman (WU)

United Health Services Hospitals, Wilson Regional Medical Center, Department of Internal Medicine, NY, USA.

Md Alom (M)

United Health Services Hospitals, Wilson Regional Medical Center, Department of Internal Medicine, NY, USA.

Vincent Skovira (V)

United Health Services Hospitals, Heart and Vascular Institute, Wilson Regional Medical Center, Department of Cardiology, NY, USA.

Nour Breiteh (N)

Center for Public Health Practice at the Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.

Ibraheem Rehman (I)

Emory University School of Medicine, Atlanta, GA, USA.

Alon Yarkoni (A)

United Health Services Hospitals, Heart and Vascular Institute, Wilson Regional Medical Center, Department of Cardiology, NY, USA.

Hisham Kahsou (H)

United Health Services Hospitals, Heart and Vascular Institute, Wilson Regional Medical Center, Department of Cardiology, NY, USA.

Afzal Rehman (A)

United Health Services Hospitals, Heart and Vascular Institute, Wilson Regional Medical Center, Department of Cardiology, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH